Considering the common links between the pathogeneses of diabetes mellitus and obesity, a healthy lifestyle supported by pharmacotherapy with PTP1B inhibitors should offer effective treatment of both diseases. This evidence concerns the gene PTPN1 and obesity due to melanocortin 4 receptor deficiency.